499 related articles for article (PubMed ID: 38534769)
1. Deciphering Glioblastoma: Fundamental and Novel Insights into the Biology and Therapeutic Strategies of Gliomas.
Onciul R; Brehar FM; Toader C; Covache-Busuioc RA; Glavan LA; Bratu BG; Costin HP; Dumitrascu DI; Serban M; Ciurea AV
Curr Issues Mol Biol; 2024 Mar; 46(3):2402-2443. PubMed ID: 38534769
[TBL] [Abstract][Full Text] [Related]
2. Gliomas in children and adolescents: investigation of molecular alterations with a potential prognostic and therapeutic impact.
Cabral de Carvalho Corrêa D; Tesser-Gamba F; Dias Oliveira I; Saba da Silva N; Capellano AM; de Seixas Alves MT; Dastoli PA; Cavalheiro S; Caminada de Toledo SR
J Cancer Res Clin Oncol; 2022 Jan; 148(1):107-119. PubMed ID: 34626238
[TBL] [Abstract][Full Text] [Related]
3. Examining the function of macrophage oxidative stress response and immune system in glioblastoma multiforme through analysis of single-cell transcriptomics.
Xing J; Cai H; Lin Z; Zhao L; Xu H; Song Y; Wang Z; Liu C; Hu G; Zheng J; Ren L; Wei Z
Front Immunol; 2023; 14():1288137. PubMed ID: 38274828
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic utility of genetic alterations in distinguishing IDH-wildtype glioblastoma from lower-grade gliomas: Insight from next-generation sequencing analysis of 479 cases.
Lee B; Hwang S; Bae H; Choi KH; Suh YL
Brain Pathol; 2024 Jan; ():e13234. PubMed ID: 38217295
[TBL] [Abstract][Full Text] [Related]
5. Uncovering Spatiotemporal Heterogeneity of High-Grade Gliomas: From Disease Biology to Therapeutic Implications.
Comba A; Faisal SM; Varela ML; Hollon T; Al-Holou WN; Umemura Y; Nunez FJ; Motsch S; Castro MG; Lowenstein PR
Front Oncol; 2021; 11():703764. PubMed ID: 34422657
[TBL] [Abstract][Full Text] [Related]
6. Integrative Analysis of Neuregulin Family Members-Related Tumor Microenvironment for Predicting the Prognosis in Gliomas.
Zhao WJ; Ou GY; Lin WW
Front Immunol; 2021; 12():682415. PubMed ID: 34054873
[TBL] [Abstract][Full Text] [Related]
7. The epitranscriptome of high-grade gliomas: a promising therapeutic target with implications from the tumor microenvironment to endogenous retroviruses.
Ramsoomair CK; Ceccarelli M; Heiss JD; Shah AH
J Transl Med; 2023 Dec; 21(1):893. PubMed ID: 38071304
[TBL] [Abstract][Full Text] [Related]
8. Cancer Metabolism: The Role of Immune Cells Epigenetic Alteration in Tumorigenesis, Progression, and Metastasis of Glioma.
Kanwore K; Kanwore K; Adzika GK; Abiola AA; Guo X; Kambey PA; Xia Y; Gao D
Front Immunol; 2022; 13():831636. PubMed ID: 35392088
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of histone acetylation-related genes in glioblastoma and lower-grade gliomas: Insights into drug sensitivity, molecular subtypes, immune infiltration, and prognosis.
Qin J; Fu J; Chen X
J Gene Med; 2024 Mar; 26(3):e3678. PubMed ID: 38500293
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel genomic markers related to progression to glioblastoma through genomic profiling of 25 primary glioma cell lines.
Roversi G; Pfundt R; Moroni RF; Magnani I; van Reijmersdal S; Pollo B; Straatman H; Larizza L; Schoenmakers EF
Oncogene; 2006 Mar; 25(10):1571-83. PubMed ID: 16247447
[TBL] [Abstract][Full Text] [Related]
11. Discovering gene-environment interactions in glioblastoma through a comprehensive data integration bioinformatics method.
Kunkle B; Yoo C; Roy D
Neurotoxicology; 2013 Mar; 35():1-14. PubMed ID: 23261424
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive characterization of TNFSF14/LIGHT with implications in prognosis and immunotherapy of human gliomas.
Han M; Sun Y; Zhao W; Xiang G; Wang X; Jiang Z; Xue Z; Zhou W
Front Immunol; 2022; 13():1025286. PubMed ID: 36341396
[TBL] [Abstract][Full Text] [Related]
13. Exploring Monocytes-Macrophages in Immune Microenvironment of Glioblastoma for the Design of Novel Therapeutic Strategies.
Caverzán MD; Beaugé L; Oliveda PM; Cesca González B; Bühler EM; Ibarra LE
Brain Sci; 2023 Mar; 13(4):. PubMed ID: 37190507
[TBL] [Abstract][Full Text] [Related]
14. Integrative multi-omics characterization reveals sex differences in glioblastoma.
Jang B; Yoon D; Lee JY; Kim J; Hong J; Koo H; Sa JK
Biol Sex Differ; 2024 Mar; 15(1):23. PubMed ID: 38491408
[TBL] [Abstract][Full Text] [Related]
15. Cellular Plasticity and Tumor Microenvironment in Gliomas: The Struggle to Hit a Moving Target.
Gargini R; Segura-Collar B; Sánchez-Gómez P
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32570988
[TBL] [Abstract][Full Text] [Related]
16. Development of immunotherapy for high-grade gliomas: Overcoming the immunosuppressive tumor microenvironment.
Franson A; McClellan BL; Varela ML; Comba A; Syed MF; Banerjee K; Zhu Z; Gonzalez N; Candolfi M; Lowenstein P; Castro MG
Front Med (Lausanne); 2022; 9():966458. PubMed ID: 36186781
[TBL] [Abstract][Full Text] [Related]
17. Tumor-Associated Macrophages in Gliomas-Basic Insights and Treatment Opportunities.
Andersen JK; Miletic H; Hossain JA
Cancers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267626
[TBL] [Abstract][Full Text] [Related]
18. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
Tian QS; Zhang Q; Huang W
Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
[TBL] [Abstract][Full Text] [Related]
19. Exploitation of immune mechanisms in the treatment of central nervous system cancer.
Pollack IF; Okada H; Chambers WH
Semin Pediatr Neurol; 2000 Jun; 7(2):131-43. PubMed ID: 10914414
[TBL] [Abstract][Full Text] [Related]
20. Dissection of transcriptomic and epigenetic heterogeneity of grade 4 gliomas: implications for prognosis.
Zeng C; Song X; Zhang Z; Cai Q; Cai J; Horbinski C; Hu B; Cheng SY; Zhang W
Acta Neuropathol Commun; 2023 Aug; 11(1):133. PubMed ID: 37580817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
